Evidation, Lilly and Apple show digital tech could identify, monitor Alzheimer’s

Data from a study by Evidation, Eli Lilly and Apple suggest digital biomarkers collected via mobile devices could be used to identify patients at risk for mild

Read the full 279 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE